Haemophilus influenzae type b conjugate vaccines: A review of efficacy data

Pediatric Infectious Disease Journal

Volumn 17, Issue 9 SUPPL., 1998, Pages

  Heath, Paul T ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Haemophilus influenzae; Haemophilus influenzae type b; United Kingdom; Vaccine

Indexed keywords

DIPHTHERIA TOXIN; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; OUTER MEMBRANE PROTEIN; TETANUS TOXOID;

AGE DISTRIBUTION; BACTERIAL INFECTION; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; FINLAND; HEALTH PROGRAM; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; INFECTION CONTROL; PRESCHOOL CHILD; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES; VACCINATION;

BACTERIAL OUTER MEMBRANE PROTEINS; CHILD, PRESCHOOL; CLINICAL TRIALS; DIPHTHERIA TOXOID; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; POLYSACCHARIDES, BACTERIAL; TETANUS TOXOID; VACCINATION; VACCINES, CONJUGATE;

EID: 0031678665     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199809001-00005     Document Type: Conference Paper

References (19)

1. Fothergill L, Wright J. Relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol 1933;24:273-84.
2. Peltola H, Käyhty H, Sivonen A. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field trial of 100 000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60:730-7.
3. Eskola J, Peltola H, Takala AK, et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med 1987;317:717-22.
4. Eskola J, Käyhty H, Takala AK, et al. A randomized prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990;323:1381-7.
5. Ward J, Brenneman G, Letson GW, Heyward WL, the Alaska H influenzae Vaccine Study Group. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaskan native infants. N Engl J Med 1990;323:1393-401.
6. Peltola H, Eskola J, Käyhty H, Takala AK, Mäkelä PH. Clinical comparison of the Haemophilus influenzae type polysaccharide-diphtheria toxoid vs. the oligosaccharide CRM197 protein vaccines in infancy. Arch Pediatr Adolesc Med 1994;148:620-5.
7. Takala A, Eskola J, Peltola H, Makela PH. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 1989;8: 297-302.
8. Black SB, Shinefield HR, Fireman B, et al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children. Pediatr Infect Dis J 1991;10:97-104.
9. Vadheim CM, Greenberg DP, Eriksen E, et al. Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study. Pediatr Infect Dis J 1994;13:274-80.
10. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324: 1767-72.
11. Booy R, Hodgson S, Carpenter L, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994; 344:362-6.
12. Vadheim C, Greenberg D, Partridge S, et al. Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Pediatrics 1993;92:272-9.
13. Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J Pediatr 1992;121:355-62.
14. Wenger JD, Booy R, Heath PT, Moxon R. Conjugate vaccines against Hib invasive disease. In: Levin MM, Woodrow GC, Kaper JB, eds. New generation vaccines. 2nd ed. chap 35. New York: Dekker, 1997:489-502.
15. Takala AK, Eskola J, Kayhty H, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunised with a Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
16. Eskola J, Kayhty H. Ten years experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland. Rev Med Microbiol 1996;7:231-41.
17. Jonsdottir KE, Hansen H, Arnorsson VH, Laxdal P, Stefansson M. Immunization against Haemophilus influenzae type b in Iceland: results after six years use of PRP-D (ProHIBiT®). Icelandic Med J 1996;82:32-8.
18. Booy R, Hodgson SA, Slack MPE, Anderson EC, Mayon-White RT, Moxon ER. Invasive Haemophilus influenzae type b disease in the Oxford Region(1985-91). Arch Dis Child 1993;69:225-8.
19. Booy R, Heath PT, Slack MPE, Begg N, Moxon ER. Vaccine failures after primary immunisation with Haemophilus influenzae type b conjugate vaccine without booster. Lancet 1997;349:1197-202.